机构地区:[1]广西壮族自治区疾病预防控制中心艾滋病性病防制科,南宁530028
出 处:《中华预防医学杂志》2010年第11期989-992,共4页Chinese Journal of Preventive Medicine
摘 要:目的观察儿童HIV感染者或AIDS患者接受高效抗反转录病毒治疗(HAART)前后T淋巴细胞及亚群的变化。方法选取2006年5月至2009年4月在广西壮族自治区疾病预防控制中心AIDS抗病毒治疗门诊接受HAART的儿童作为研究对象,共招募99例儿童HIV感染者或AIDS患者。分别在治疗前(D0),治疗后第3、6、12、18、24、30、36个月(M3、M6、M12、M18、M24、M30、M36)时随访调查并采集2ml静脉血,应用四色荧光标记流式细胞术检测外周血CD3^+、CD4^+、CD8^+T淋巴细胞绝对数及CD3比率、CD4比率、CD8比率、CD4/CD8比值。结果99例研究对象的治疗方案为:拉米夫定(3TC)/齐多夫定(AZT)/奈韦拉平(NVP),65例(65.66%);3TC/司他夫定(D4T)/NVP,16例(16.16%);3TC/AZT/依非韦伦(EFV),8例(8.08%);3TC/AZT/克力芝(LPV/r),10例(10.10%)。CD4/CD8比值的中位数在M3、M6、M12、M18、M24、M30、M36时分别为0.39、0.51、0.61、0.65、0.70、0.73、0.76,与DO时(0.19)比较,均有明显提高(Z值分别为-5.158、-7.375、-9.078、-8.853、-8.373、-5.845、-5.844,P值均〈0.000)。CD4比率的中位数在M3、M6、M12、M18、M24、M30、M36时分别为16.92%、22.70%、25.54%、26.66%、27.99%、30.36%、29.30%,与DO时(9.92%)比较,均有明显提高(Z值分别为-5.268、-7.568、-9.496、-9.171、-8.760、-6.190、-5.964,P值均〈0.000)。CD4^+T淋巴细胞绝对数的中位数在M3、M6、M12、M18、M24、M30、M36时分别为631、813、1050、946、1057、1166、894个/mm^3,与DO时(382个/mm^3)比较,均有明显提高(Z值分别为-3.318、-5.288、-6.661、-5.886、-5.801、-4.110、-3.600,P值均〈0.000)。CD8比率的中位数在M3、M6、M12、M18、M24、M30、M36时分别为47.25%、43.01%、43.04%、42.60%、41�Objective To investigate the changes of the T lymphocytes and their subsets before and after receiving highly active anti-retroviral therapy (HAART) in children who were infected with HIV or AIDS patients. Methods Ninety-nine children met the criteria were recruited. All of them had received HAART in Guangxi Center for Disease Control and Prevention from May 2006 to April 2009. Peripheral blood of 2 milliliter was collected before treatment (D0) and after 3,6,12,18,24,30, and 36 months ( M3, M6, M I2,M18, M24, M30 and M36) , respectively. Four-color fluorescence flow cytometry was used for the detection of the absolute numbers of CD3^+ , CD4^+ , CD8^ + T lymphocytes in peripheral blood. And then,the percentages of CD3 ^+ , CD4^ + , CD8 ^+ T lymphocytes in the CD45^ + cells and the ratio of CD4/CD8 were calculated. Results Sixteen-five (65.66%) cases were treated with lamivudine ( 3TC)/zidovudine ( AZT)/nevirapine ( NVP), and 16 ( 16. 16% ), 8 ( 8.08% ) and 10 ( 10. 10% ) cases were treated with 3TC/stavudine ( D4T)/NVP,3TC/AZT/efavirenz (EFV) and 3TC/AZT/lpv-rtv (LPV/r) ,respectively. The median of the ratio of CD4/CD8 were 0. 39,0. 51,0. 61,0. 65,0. 70,0. 73 and 0. 76 in M3 ,M6,M12,M18, M24,M30 and M36, respectively which were siguificantly higher than that in DO (0. 19) ( Z values were -5. 158, -7. 375, - 9. 078, - 8. 853, - 8. 373, - 5. 845 and - 5. 844 respectively, P 〈 0. 1300). The median of CD4% were 16. 92% ,22. 70% ,25.54% ,26. 66% ,27.99% ,30. 36% and 29. 30% respectively in M3,M6, M12, M IS, M24, M30 and M36 respectively,which were also higher significantly than that in DO (9. 92%) (Zvalues were -5.268, - 7. 568, - 9. 496, - 9. 171, - 8. 760, - 6. 190 and -5.964 respectively, P 〈 0. 000) . In addition, the median of the absolute numbers of CD4^ + T lymphocytes in peripheral blood were 631,813,1050,946,1057,1166 and 894 cells/mm^3 respectively in M3, M6, M12, M18, M24, M30 and M36, which were higher significantly th
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...